Author

Hardik Bhatt

Observed names: Bhatt, Hardik, Bhatt, Hardik G., H. Bhatt, H. G. Bhatt, H.G. Bhatt, HG Bhatt, Hardik G Bhatt, Hardik G. Bhatt, Hardik Girishkumar Bhatt

Institution: Nirma University

Observed institution: Nirma University

ORCID: 0000-0002-6431-0695

Observed ORCID: 0000-0002-6431-0695

OpenAlex ID: A5077225821

A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies

2017 · Ankit C. Borisa, Hardik G. Bhatt · European Journal of Medicinal Chemistry · 178

Therapeutic potential of snake venom in cancer therapy: current perspectives

2013 · Vivek Kumar Vyas, Keyur Brahmbhatt, et al. · Asian Pacific Journal of Tropical Biomedicine · 169

PDF

Neuroprotective effects of bergenin in Alzheimer’s disease: Investigation through molecular docking, in vitro and in vivo studies

2018 · Priyal Barai, Nisith Raval, et al. · Behavioural Brain Research · 93

Design, synthesis and anti-HIV activity of novel quinoxaline derivatives

2016 · Saloni B. Patel, Bhumika D. Patel, et al. · European Journal of Medicinal Chemistry · 61

3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer

2015 · Udit Chaube, Dhara Chhatbar, et al. · Bioorganic & Medicinal Chemistry Letters · 46

Synthesis, docking, and biological investigations of new coumarin-piperazine hybrids as potential antibacterial and anticancer agents

2022 · Kajalben B. Patel, Sudipta Mukherjee, et al. · Journal of Molecular Structure · 45

Chirality - A New Era of Therapeutics

2007 · Y. Agrawal, H. Bhatt, et al. · Mini-Reviews in Medicinal Chemistry · 45

Telomerase: A prominent oncological target for development of chemotherapeutic agents

2023 · Keerti Vishwakarma, Rajdeep Dey, et al. · European Journal of Medicinal Chemistry · 44

CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer

2019 · Dhara M. Chhatbar, Udit J. Chaube, et al. · Computational Biology and Chemistry · 43

Synthesis, Molecular Docking and Biological Evaluation of Mannich Products Based on Thiophene Nucleus using Ionic Liquid

2018 · H.M. Patel, D.P. Rajani, et al. · Letters in Drug Design & Discovery · 42

In silico study to quantify the effect of exercise on surface GLUT4 translocation in diabetes management

2021 · Darshna M. Joshi, Jignesh Patel, et al. · Network Modeling Analysis in Health Informatics and Bioinformatics · 41

Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents

2006 · Mahesh T. Chhabria, Hardik G. Bhatt, et al. · Bioorganic & Medicinal Chemistry Letters · 41

3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) and molecular docking study of thienopyrimidine and thienopyridine derivatives to explore structural requirements for aurora-B kinase inhibition

2015 · Ankit Borisa, Hardik Bhatt · European Journal of Pharmaceutical Sciences · 38

Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses

2010 · H. G. Bhatt, Y. K. Agrawal, et al. · Mini-Reviews in Medicinal Chemistry · 35

3D-QSAR (CoMFA, CoMSIA, HQSAR and topomer CoMFA), MD simulations and molecular docking studies on purinylpyridine derivatives as B-Raf inhibitors for the treatment of melanoma cancer

2019 · Jaydeepsinh Chavda, Hardik Bhatt · Structural Chemistry · 31

Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)

2021 · Chirag C. Mehta, Hardik G. Bhatt · Expert Opinion on Therapeutic Patents · 28

CoMFA and CoMSIA studies onC-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents

2013 · V. K. Vyas, H. G. Bhatt, et al. · SAR and QSAR in environmental research · 27

A supercritical fluid chromatography/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma

2010 · YK Agrawal, PJ Gogoi, et al. · Indian Journal of Pharmaceutical Sciences · 27

PDF

Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer

2020 · Udit J. Chaube, Rakesh Rawal, et al. · Bioorganic Chemistry · 26

Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer

2020 · Jaydeepsinh Chavda, Hardik Bhatt · European Journal of Medicinal Chemistry · 25

3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors

2017 · Udit Chaube, Hardik Bhatt · Molecular Diversity · 24

Tetrahydroquinoline: An Efficient Scaffold As mTOR Inhibitor for the Treatment of Lung Cancer

2022 · Udit Chaube, Rajdeep Dey, et al. · Future Medicinal Chemistry · 23

3D-QSAR studies on 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4- carboxamide derivatives as HIV-1 integrase inhibitors

2015 · Saloni Patel, Bhumika Patel, et al. · Journal of the Taiwan Institute of Chemical Engineers · 22

Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors

2012 · Hardik G. Bhatt, Paresh K. Patel · Bioorganic & Medicinal Chemistry Letters · 21

Development of Green RP- and Green NP-HPTLC Methods for Estimation of Lenvatinib and Comparative Evaluation by AGREE

2023 · Pratiksha P. Bang, Hardik G. Bhatt · ACS Sustainable Chemistry & Engineering · 20

Works count: 93

Citation count: 1,478

H-index: 22

I10-index: 35